Pamela Stephenson
Förmögenhet: 1 M $ per 2026-05-31
Förmögenhet: 1 M $ per 2026-05-31
Pamela Stephenson is Chief Commercial Officer at Disc Medicine, Inc. since 2024.
Formerly, Ms. Stephenson was Chief Commercial Officer at Albireo Pharma, Inc. from 2019 to 2023, Independent Director at Harmony Biosciences Management, Inc. from 2019 to 2023, and Vice President-Global Market Access & Value at Vertex Pharmaceuticals, Inc. from 2008 to 2019.
Education includes undergraduate studies at Brown University and graduate studies at Boston University School of Public Health.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
DISC MEDICINE, INC. 0,05 % | 2026-04-22 | 18 665 ( 0,05 % ) | 1 M $ | 2026-05-31 |
| Företag | Position | Start |
|---|---|---|
| DISC MEDICINE, INC. | Företagsledare/Principal | 2024-02-26 |
| Företag | Position | Slut |
|---|---|---|
| ZYNERBA PHARMACEUTICALS, INC. | Direktör/Styrelseledamot | 2023-10-10 |
| ALBIREO PHARMA, INC. | Företagsledare/Principal | 2023-04-01 |
| VERTEX PHARMACEUTICALS INCORPORATED | Företagsledare/Principal | 2019-03-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 6 |
|---|---|
Vertex Pharmaceuticals, Inc.
Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
Zynerba Pharmaceuticals, Inc.
Zynerba Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Delivers dermal solutions for the treatment of neuroscience disorders | Health Technology |
Brown University
Brown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boston University School of Public Health
Boston University School of Public Health Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Albireo Pharma, Inc.
Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets novel bile acid modulators for liver and gastrointestinal diseases and disorders | Health Technology |
Disc Medicine, Inc.
Disc Medicine, Inc. BiotechnologyHealth Technology Develops therapies addressing red blood cell production in hematologic diseases | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån